BioSpace News Archive

Bristol-Myers Squibb Company announced the extension of the expiration date of the offers to exchange notes issued by Celgene Corporation for up to $19,850,000,000 aggregate principal amount of new notes to be issued by Bristol-Myers Squibb Company and cash and the related consent solicitations being made by Bristol-Myers Squibb on behalf of Celgene to adopt certain proposed amendments to the indentures governing the Celgene Notes.

ArQule, Inc. announced that it will be presenting research on the company’s pan-AKT inhibitor, miransertib, in a poster presentation at the 2019 ASHG Annual Meeting being held from October 15 to October 19, 2019 in Houston, Texas.

$0 Copay for Generic Drugs at Home Delivery (Up to 90-Day Supply) Through the Express Scripts Saver, Value and Choice Plans

In two head-to-head clinical trials, patients on BEOVU (brolucizumab-dbll) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients

Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2020 first-quarter conference call on Tuesday, October 29, 2019, at 3:30 p.m. CT (4:30 p.m. ET).

Acquisition Adds One of Only 10 Vertically Integrated Cannabis Business Licenses Issued by the State of New York

Automated Digital Patient Management Increases Care Quality, Staff Efficiency and Revenue

Investigational Therapy Designed to Engineer Patients’ Own Stem Cells to Produce Essential Protein

The prize was awarded for their work on discovering how cells detect and respond to changes in oxygen availability, a process that is key to the survival of many cancers.

This is the eighth year the organization has been named to the list.